The clinical effectiveness of telehealth: A systematic review of meta-analyses from 2010 to 2019

Abstract

Introduction To promote telehealth implementation and uptake, it is important to assess overall clinical effectiveness to ensure any changes will not adversely affect patient outcomes. The last systematic literature review examining telehealth effectiveness was conducted in 2010. Given the increasing use of telehealth and technological developments in the field, a more contemporary review has been carried out. The aim of this review was to synthesise recent evidence associated with the clinical effectiveness of telehealth services. Methods A systematic search of ‘Pretty Darn Quick’-Evidence portal was carried out in November 2020 for systematic reviews on telehealth, where the primary outcome measure reported was clinical effectiveness. Due to the volume of telehealth articles, only systematic reviews with meta-analyses published between 2010 and 2019 were included in the analysis. Results We found 38 meta-analyses, covering 10 medical disciplines: cardiovascular disease ( n = 3), dermatology ( n = 1), endocrinology ( n = 13), neurology ( n = 4), nephrology ( n = 2), obstetrics ( n = 1), ophthalmology ( n = 1), psychiatry and psychology ( n = 7), pulmonary ( n = 4) and multidisciplinary care ( n = 2). The evidence showed that for all disciplines, telehealth across a range of modalities was as effective, if not more, than usual care. Discussion This review demonstrates that telehealth can be equivalent or more clinically effective when compared to usual care. However, the available evidence is very discipline specific, which highlights the need for more clinical effectiveness studies involving telehealth across a wider spectrum of clinical health services. The findings from this review support the view that in the right context, telehealth will not compromise the effectiveness of clinical care when compared with conventional forms of health service delivery.

Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study

“…Opportunities of telemedicine are numerous [ 13 ] and have been demonstrated in multiple medical domains [ 14 ], an example of which is cardiology care: Telemedicine support may help to overcome diagnostic delays [ 15 ] and even reduce mortality in heart failure [ 16 ]. Furthermore, telemedicine can increase the efficiency of health care, shorten travel distances, facilitate access to health care services [ 17 ], and thus might reduce socioeconomic barriers [ 18 ]—aspects that are also discussed as potentials of telemedicine in rheumatology care (telerheumatology) [ 19 , 20 , 21 , 22 ].…”

Patient and Provider Views on Psychosocial Screening in a Comprehensive Diabetes Center

“…Although not a topic presented to participants in the current study, an important avenue for future research is how to implement screening programs and integrated mental health services for patients with diabetes via telehealth. Demand for telehealth services have increased dramatically as a result of the COVID-19 pandemic (Wong et al, 2021 ), and telehealth appears to be an effective modality (Snoswell et al, 2021 ). Some patients will undoubtedly continue to prefer telehealth services even after the pandemic wanes given the increased convenience and flexibility.…”

Changing from telephone to videoconference for pre-treatment pharmacist consults in cancer services: Impacts to funding and time efficiency

“…In terms of patient outcomes, a systematic review found that videoconference was comparable to telephone for healthcare delivery, although cancer pharmacy services were not specifically studied. 15 An integrated model 16 would best support patient and service needs by taking into account such factors as technology, convenience, 6 inclusion of support people, and the ability to view patient's medicine containers and labels. For sustainability and scalability of telehealth using videoconference, setting a target for a proportion of consults to be via videoconference has been recommended 17 as part of an organisation's e-strategy.…”

“…Benefits derived from using videoconference have been described in several studies in a variety of health care settings and professions. [4][5][6] There are very few pharmacy-specific telehealth (telephone or videoconference) studies in either Australia [7][8] or internationally. [9][10][11] Furthermore, in Australia, there is no evidence comparing pharmacist telephone and videoconference consults, or pharmacist-obtained medication histories via videoconference for patients with cancer at their preferred location (e.g.…”